Vafidemstat,1357362-02-7

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Vafidemstat

CAS No. : 1357362-02-7

MCE 国际站：Vafidemstat

产品活性：Vafidemstat (ORY-2001) 是一种双重的赖氨酸特异性组蛋白去甲基化酶 (LSD1)/MAO-B 抑制剂。

研究领域：Epigenetics  |  Neuronal Signaling

作用靶点：Histone Demethylase  |  Monoamine Oxidase

In Vitro: Vafidemstat (ORY-2001), a dual LSD1/MAO-B inhibitor, is a novel epigenetic agent for the treatment of neurodegenerative diseases. LSD1 is a protein that participates in transcription regulation complexes; its modulation can be used to tweak transcriptional imbalances in neurodegenerative disease and redress neuroinflammation and cognitive deficit. Vafidemstat (ORY-2001) can be used in the treatment of Alzheimer's disease.

相关产品：Drug Repurposing Compound Library  |  Reprogramming Compound Library  |  Neuronal Signaling Compound Library  |  Clinical Compound Library  |  Clinical Compound Library Plus  |  Drug Repurposing Compound Library Plus  |  Epigenetics Compound Library  |  Bioactive Compound Library Plus  |  Histone Modification Research Compound Library  |  Anti-Alzheimer’s Disease Compound Library  |  GSK-J4  |  QC6352  |  SP2509  |  GSK2879552  |  ORY-1001(trans)  |  Corin  |  Seclidemstat  |  CPI-455  |  JIB-04  |  Rosmarinic acid  |  IOX1  |  GSK-LSD1 dihydrochloride  |  Tranylcypromine hemisulfate  |  Methylene Blue  |  Clorgyline hydrochloride  |  KDOAM-25 citrate  |  NCGC00244536  |  KDM5-C70  |  (2-Chloropyridin-4-yl)methanamine hydrochloride  |  KDM5-IN-1  |  L-2-Hydroxyglutaric acid disodium  |  PAT-1251  |  Paeonol  |  Daminozide  |  KDM5A-IN-1  |  PXS-5153A monohydrochloride  |  Rasagiline mesylate  |  β-Aminopropionitrile  |  Pargyline hydrochloride

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪制药及生命科学研究进展，为您提供全球活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。